GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 125 filers reported holding GOSSAMER BIO INC in Q4 2020. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,485,600 | +712.7% | 1,238,000 | +753.3% | 0.00% | – |
Q1 2023 | $182,796 | -41.9% | 145,076 | 0.0% | 0.00% | -100.0% |
Q4 2022 | $314,815 | -84.1% | 145,076 | -12.4% | 0.00% | -80.0% |
Q3 2022 | $1,984,000 | +47.2% | 165,616 | +2.8% | 0.01% | +66.7% |
Q2 2022 | $1,348,000 | +2.7% | 161,106 | +6.6% | 0.00% | 0.0% |
Q1 2022 | $1,312,000 | -23.3% | 151,166 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $1,710,000 | -6.2% | 151,166 | +4.2% | 0.00% | -25.0% |
Q3 2021 | $1,824,000 | +54.8% | 145,076 | 0.0% | 0.00% | +100.0% |
Q2 2021 | $1,178,000 | -12.2% | 145,076 | 0.0% | 0.00% | -33.3% |
Q1 2021 | $1,342,000 | -24.0% | 145,076 | -20.5% | 0.00% | -25.0% |
Q4 2020 | $1,766,000 | -22.0% | 182,547 | 0.0% | 0.00% | -33.3% |
Q3 2020 | $2,265,000 | -10.6% | 182,547 | -6.3% | 0.01% | -14.3% |
Q2 2020 | $2,533,000 | +20.5% | 194,828 | -5.9% | 0.01% | 0.0% |
Q1 2020 | $2,102,000 | -47.1% | 207,065 | -18.6% | 0.01% | -36.4% |
Q4 2019 | $3,976,000 | – | 254,309 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 8,055,916 | $6,708,967 | 4.36% |
Velan Capital Investment Management LP | 3,065,136 | $2,552,645 | 2.06% |
Monashee Investment Management LLC | 5,304,212 | $4,417,348 | 1.84% |
CVI Holdings, LLC | 976,108 | $812,903 | 1.61% |
Samsara BioCapital, LLC | 6,130,268 | $5,105,287 | 1.56% |
SILVERARC CAPITAL MANAGEMENT, LLC | 6,130,268 | $5,105,287 | 1.55% |
Opaleye Management Inc. | 4,754,200 | $3,959,298 | 1.29% |
Octagon Capital Advisors LP | 8,187,883 | $6,818,869 | 1.05% |
NEA Management Company, LLC | 15,727,942 | $13,098,230 | 1.01% |
GREAT POINT PARTNERS LLC | 6,230,272 | $5,188,571 | 0.94% |